TY - JOUR
T1 - First report on infant acute urticaria after mother's parenteral use of meglumine antimoniate (Glucantime): A case report
AU - Mozafari, Omid
AU - Shorofi, Seyed
AU - Yousefi, Seyde
PY - 2016/9/27
Y1 - 2016/9/27
N2 - Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother’s parenteral use of meglumine antimoniate (glucantime).
AB - Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother’s parenteral use of meglumine antimoniate (glucantime).
KW - Adverse reactions
KW - Cutaneous leishmaniasis
KW - Meglumine antimoniate (Glucantime)
UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149476/pdf/IJPH-45-1217.pdf
UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149476/
UR - http://www.scopus.com/inward/record.url?scp=84988958794&partnerID=8YFLogxK
M3 - Article
SN - 2251-6085
VL - 45
SP - 1217
EP - 1219
JO - Iranian Journal of Public Health
JF - Iranian Journal of Public Health
IS - 9
ER -
